|
|
| Maladies Cardiovasculaires > Etude de marché sectorielle |
| Chinese Markets for Cardiovascular Drugs |
|
|
|
|
€ 2 835,00 |
Editeur
: |
Amid Co |
Langue
: |
Anglais |
Date de publication : |
Octobre 2002 |
Taille du document : |
235 |
Autres informations : |
Description , Table des matières |
| |
|
|
|
|
| |
|
Rechercher d'autres rapports et études à commander
Rechercher et commander ici parmi 50.000 études de marché publiées par les principaux instituts d'études internationaux
|
| Rapports privés en relation |
|
PharmaVitae 2005: Novo Nordisk Global Analysis
128 pages | Octobre 2005 |
IntroductionThis analysis examines the current position and future outlook for Novo Nordisk in the ethical pharmaceutical sector.
The profile encompasses global company strategy, portfolio and pipe |
3 230,00 €
|
| |
| |
Event Analysis and Response Service: Cox-2s - Cox-2 Crisis Dents Big Pharma Confidence
95 pages | Juin 2005 |
IntroductionOn 30th September 2004, Merck withdrew its blockbuster drug Vioxx from the global market after trial data reinforced the suspicion that it increased the risk of cardiovascular events.
V |
9 120,00 €
|
| |
| |
Pipeline Insight: Antithrombotics - Anticoagulants and Antiplatelets Have Blockbuster Potential
383 pages | Octobre 2005 |
IntroductionDatamonitor estimates the total revenue generated from new antithrombotics in the seven major markets will reach approximately $10bn by 2015, with novel oral anticoagulants contributing ov |
9 690,00 €
|
| |
| |
Nutraceuticals - Targeting Consumers Aged 35+
154 pages | Septembre 2000 |
Not only does the 35+ consumer group account for a significant and growing percentage of the total population; it is also at the greatest risk of major illnesses.
Despite advances in medicine |
955,00 €
|
| |
| |
Stakeholder Insight: Acute Stroke - Symptom Awareness Will Reduce Headache
154 pages | Avril 2005 |
IntroductionStroke is one of the top three causes of death and incidence is expected to increase in the next ten years.
Long term disability caused by stroke is a major economic burden on healthcar |
12 160,00 €
|
| |
| |
UK Pet Insurance 2005
76 pages | Juillet 2005 |
IntroductionUK Pet Insurance 2005 reviews the recent performance of the market and considers the key drivers of its development in the future.
Exclusive data covering market size, distribution and |
2 236,00 €
|
| |
| |
The World Hypertension Market 2005-2010
185 pages | Novembre 2005 |
The world hypertension market generated over $25 billion in 2004, with steady growth from the previous year.
In this report, visiongain forecasts that revenues in the world hypertension market will |
2 663,00 €
|
| |
| |
Cardiac Pacemakers
237 pages | Octobre 2005 |
This report analyzes the worldwide markets for Cardiac Pacemakers in Millions of US$.
The major product segments analyzed are Implantable Pacemakers, and External Pacemakers.
The sub product seg |
3 091,00 €
|
| |
| |
US Cholesterol-Reducing Statins 2004
12 pages | Décembre 2004 |
Snapdata's US Cholesterol-Reducing Statins 2004 report provides 2003 year-end market data, with 2004 estimates and five-year forecasts.
The report gives an instant overview of the US cholesterol-re |
240,00 €
|
| |
| |
Computed Tomography Scanners
188 pages | Octobre 2005 |
This report analyzes the worldwide markets for Computed Tomography Scanners in Units.
The major product segments analyzed are Single Slice CT Scanners, Multi Slice CT Scanners, and Cardiac/EBT Scan |
2 699,00 €
|
| |
| |
|
| |
| Autres secteurs en relation |
|
|
|
| |
|
| |
| |
| Présentation de l'étude de marché - Description & Table des matières |
|
| Chinese Markets for Cardiovascular Drugs |
|
|
China's demand for cardiovascular drugs has grown at a fast pace in the past decade. In the next five years, both production and demand will continue to grow. This new study examines China's economic trends, investment environment, industry development, supply and demand, industry capacity, industry structure, marketing channels and major industry participants. Historical data (1991, 1996 and 2001) and long-term forecasts throught 2006 and 2011 are presented. Major producers in China are profiled.
|
|
TABLE OF CONTENTS
I. INTRODUCTION
Report Scope and Methodology
Executive Summary
II. BUSINESS ENVIRONMENT
Economic Outlook
Key Economic Indicators
Industrial Output
Population and Labor
Foreign Investment
Foreign Trade
Financial and Tax Regulations
Banking System and Regulations
Foreign Exchange
Taxes, Tariff and Custom Duties
III. CARDIOVASCULAR DRUGS INDUSTRY ASSESSMENTS
Cardiovascular Drugs Industry Structure
Market Size
Major Producer Facility Locations and Output
Market Share of Key Producers
Labor Costs
Potential Entrants
Major Distributors
Major Foreign Investments
Technology Development
IV. CARDIOVASCULAR DRUGS OUTPUTS AND FORECASTS
Overview
Western Cardiovascular Drugs Production and Demand
Western Cardiovascular Drugs Introduction
Major Producers
Foreign Trade
Total Output and Demand
Pricing Trends
Output and Demand for Kinds of Cardiovascular Diseases
Drugs for Cardiac Insufficiency
Antiarrhythmic Drugs
Antianginal Drugs
Antihyperlipidemia Drugs
Antihypertensive Drugs
Peripheral Angiolencs
Antishock Drugs
The Others
Output and Demand by Region
Northeast
North
Southeast
Central South
Southwest
Northwest
Chinese Traditional Cardiovascular Drugs Production & Demand
Chinese Traditional Cardiovascular Drugs Introduction
Major Producers
Foreign Trade
Total Output and Demand
Pricing Trends
Production and Demand for Kinds of Cardiovascular Diseases Treatment
Drugs for Cardiac Insufficiency
Antiarrhythmic Drugs
Antianginal Drugs
Antihyperlipidemia Drugs
Antihypertensive Drugs
Peripheral Angiolencs
Antishock Drugs
The Others
Output and Demand by Region
Northeast
North
Southeast
Central South
Southwest
Northwest
V. CARDIOVASCULAR DRUGS MARKET OUTLOOKS
Cardiovascular Drugs Markets Outlook Overview
Government Cardiovascular Drugs Regulations
Health Care Insurance Industry Overview
China’s Health Care and Cardiovascular Disease Treatment Overview
Treatment revenues
Hospitals
Physicians
China’s Population Overview
Population by Region
Northeast
North
Southeast
Central South
Southwest
Northwest
Population by Age Group
China’s Cardiovascular Diseases Patients Overview
China’s Cardiovascular Diseases Patients by Region
Northeast
North
Southeast
Central South
Southwest
Northwest
China’s Cardiovascular Diseases Patients by Age Group
Cardiovascular Diseases Patients Spending Trends
VI. MARKETING STRATEGIES
Distribution System in China
China's Distribution System
The Pharmaceuticals Distribution Channels
Transportation and Freight Infrastructure
Communications
Market Entry Channels
Exporting to China
Export Market Overview
Chinese Trading Practice
Trading Companies
Import Restrictions in China
Technology Licensing
Technology Licensing Overview
Intellectual Property Protection
Joint Venture
Joint Venture Overview
Advantages and Disadvantages
Wholly Owned Enterprises
Foreign Wholly Owned Enterprises Overview
Advantages and Disadvantages
Other Market Entry Channels
Setting up Sales Offices
Selling to China Through Attending Trade Fairs
Contacting Chinese Companies
Advertising
Market Entry Strategies
Understanding Differences
Business Practice Differences
Knowledge of Regulations and Restrictions
Dealing with Governments
VII. CARDIOVASCULAR DRUGS PRODUCERS PROFILES AND DIRECTORY
Western Cardiovascular Drugs Producers Profiles
Chinese Traditional Cardiovascular Drugs Producers Profiles
Cardiovascular Diseases Treatment Hospital Profiles
Distributors
Trading Companies
Research Institutions and Associations
LIST OF TABLES
I. INTRODUCTION
Report Scope and Methodology
Executive Summary
II. BUSINESS ENVIRONMENT
Key Economic Indicators
Industrial Output
Population and Labor Force Trends
Foreign Investment and Loans
Foreign Trade
Key Commodity Exports from China
China’s Exports to its Leading Trade Partners
Key Commodity Imports into China
China’s Imports from Its Leading Trade Partners
III. CARDIOVASCULAR DRUGS INDUSTRY ASSESSMENTS
Major Producer Facility Locations and Output
Market Share of Key Producers
Major Distributors
Major Foreign Investments
IV. CARDIOVASCULAR DRUGS OUTPUTS AND FORECASTS
Total Cardiovascular Drugs Output and Demand
Western Cardiovascular Drugs Production and Demand
Major Producers
Foreign Trade
Total Output and Demand
Production and Demand for Kinds of Cardiovascular Diseases
Drugs for Cardiac Insufficiency
Antiarrhythmic Drugs
Antianginal Drugs
Antihyperlipidemia Drugs
Antihypertensive Drugs
Peripheral Angiolencs
Antishock Drugs
The Others
Production and Demand by Region
Northeast
North
Southeast
Central South
Southwest
Northwest
Chinese Traditional Cardiovascular Drugs Production & Demand
Major Producers
Foreign Trade
Total Output and Demand
Production and Demand for Kinds of Cardiovascular Diseases Treatment
Drugs for Cardiac Insufficiency
Antiarrhythmic Drugs
Antianginal Drugs
Antihyperlipidemia Drugs
Antihypertensive Drugs
Peripheral Angiolencs
Antishock Drugs
The Others
Output and Demand by Region
Northeast
North
Southeast
Central South
Southwest
Northwest
V. CARDIOVASCULAR DRUGS MARKET OUTLOOKS
China’s Health Care and Cardiovascular Disease Treatment Overview
Treatment revenues
Hospitals
Physicians
China’s Population Overview
Population by Region
Northeast
North
Southeast
Central South
Southwest
Northwest
Population by Age Group
China’s Cardiovascular Diseases Patients Overview
China’s Cardiovascular Diseases Patients by Region
Northeast
North
Southeast
Central South
Southwest
Northwest
China’s Cardiovascular Diseases Patients by Age Group
Cardiovascular Diseases Patients Spending Trends
LIST OF CHARTS
Cardiovascular Drugs Production and Demand Summary
China's GDP and Industrial Output
Population Trends
Industrial Output by Ownership
Foreign Investments and Loans
China’s Imports and Exports
Key Commodity Exports from China
Key Commodity Imports into China
Cardiovascular Drugs Output and Demand
Cardiovascular Drugs Production in 2001
Cardiovascular Drugs Demand by Market in 2006
|
|
|
PPLSEN
|
|
|
|
|
